News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
292,705 Results
Type
Article (15646)
Company Profile (299)
Press Release (276754)
Multimedia
Podcasts (79)
Webinars (11)
Section
Business (81955)
Career Advice (177)
Deals (13802)
Drug Delivery (42)
Drug Development (51784)
Employer Resources (31)
FDA (6363)
Job Trends (5413)
News (149880)
Policy (11035)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (956)
Accelerated approval (19)
Adcomms (15)
Allergies (87)
Alliances (22281)
ALS (124)
Alzheimer's disease (1059)
Antibody-drug conjugate (ADC) (242)
Approvals (6569)
Artificial intelligence (266)
Autoimmune disease (113)
Automation (9)
Bankruptcy (133)
Best Places to Work (4781)
BIOSECURE Act (6)
Biosimilars (103)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (345)
Cancer (3150)
Cardiovascular disease (242)
Career advice (163)
Career pathing (8)
CAR-T (217)
CDC (6)
Cell therapy (565)
Cervical cancer (14)
Clinical research (44695)
Collaboration (1162)
Company closure (2)
Compensation (597)
Complete response letters (39)
COVID-19 (1160)
CRISPR (86)
C-suite (555)
Cystic fibrosis (112)
Data (4414)
Denatured (15)
Depression (96)
Diabetes (262)
Diagnostics (1425)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (189)
Drug pricing (60)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (32732)
Editorial (29)
Employer branding (4)
Employer resources (29)
Events (52809)
Executive appointments (631)
FDA (8187)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (992)
Gene editing (182)
Generative AI (21)
Gene therapy (487)
GLP-1 (511)
Government (1266)
Grass and pollen (3)
Guidances (171)
Healthcare (7043)
HIV (20)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (194)
Immuno-oncology (39)
Indications (68)
Infectious disease (1266)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (38)
Intellectual property (173)
Interviews (21)
IPO (7550)
IRA (15)
Job creations (897)
Job search strategy (140)
JPM (41)
Kidney cancer (9)
Labor market (23)
Layoffs (255)
Leadership (10)
Legal (1793)
Liver cancer (42)
Longevity (11)
Lung cancer (421)
Lymphoma (253)
Machine learning (26)
Management (7)
Manufacturing (384)
MASH (130)
Medical device (3156)
Medtech (3165)
Mergers & acquisitions (6882)
Metabolic disorders (738)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (71)
Neuroscience (1994)
Neurotech (1)
NextGen: Class of 2026 (2175)
Non-profit (1034)
Now hiring (30)
Obesity (336)
Opinion (136)
Ovarian cancer (131)
Pain (158)
Pancreatic cancer (168)
Parkinson's disease (235)
Partnered (12)
Patents (315)
Patient recruitment (335)
Peanut (44)
People (27060)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15625)
Phase 2 (20606)
Phase 3 (13330)
Pipeline (3327)
Policy (102)
Postmarket research (943)
Preclinical (6579)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (655)
Real estate (1488)
Recruiting (12)
Regulatory (10444)
Reports (19)
Research institute (996)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (123)
Series A (185)
Series B (137)
Service/supplier (1)
Sickle cell disease (78)
Special edition (18)
Spinal muscular atrophy (120)
Sponsored (16)
Startups (2038)
State (1)
Stomach cancer (5)
Supply chain (36)
Tariffs (23)
The Weekly (63)
Vaccines (342)
Venture capital (70)
Weight loss (179)
Women's health (27)
Worklife (4)
Date
Last 7 days (351)
Last 30 days (1234)
Last 365 days (18251)
2026 (1688)
2025 (18556)
2024 (21106)
2023 (22948)
2022 (27554)
2021 (28654)
2020 (24401)
2019 (17033)
2018 (12512)
2017 (14288)
2016 (12355)
2015 (14972)
2014 (10857)
2013 (7869)
2012 (7935)
2011 (8042)
2010 (7808)
Location
Africa (174)
Alabama (65)
Alaska (2)
Arizona (80)
Arkansas (6)
Asia (18694)
Australia (3206)
California (7264)
Canada (1877)
China (776)
Colorado (250)
Connecticut (254)
Delaware (245)
Europe (40197)
Florida (945)
Georgia (226)
Hawaii (2)
Idaho (18)
Illinois (404)
India (35)
Indiana (170)
Iowa (8)
Japan (224)
Kansas (84)
Kentucky (10)
Louisiana (8)
Maine (12)
Maryland (750)
Massachusetts (5625)
Michigan (114)
Minnesota (267)
Mississippi (3)
Missouri (34)
Montana (16)
Nebraska (5)
Nevada (37)
New Hampshire (21)
New Jersey (1768)
New Mexico (13)
New York (1781)
North Carolina (855)
North Dakota (6)
Northern California (3533)
Ohio (200)
Oklahoma (11)
Oregon (25)
Pennsylvania (1294)
Puerto Rico (10)
Rhode Island (25)
South America (239)
South Carolina (10)
Southern California (2905)
Tennessee (43)
Texas (953)
United States (23986)
Utah (100)
Virginia (137)
Washington D.C. (39)
Washington State (594)
West Virginia (2)
Wisconsin (47)
292,705 Results for "relief therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
December 15, 2025
·
4 min read
Press Releases
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
November 17, 2025
·
5 min read
Press Releases
The Longevity Centers of America Introduces Minimally Invasive NanoScope Needle Arthroscopy for Joint Pain Relief
January 30, 2026
·
5 min read
Press Releases
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
October 29, 2025
·
5 min read
Press Releases
Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”
January 9, 2026
·
3 min read
Press Releases
Relief Therapeutics Publishes 2025 Half-Year Report
August 14, 2025
·
2 min read
Press Releases
Relief Therapeutics Advances Publication of 2025 Half-Year Report
August 11, 2025
·
1 min read
Press Releases
Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief
January 20, 2026
·
7 min read
Press Releases
Philadelphia Allergy Experts at Becker ENT & Allergy Discuss Proven Methods for Seasonal Allergy Relief
December 30, 2025
·
6 min read
Press Releases
Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze
July 29, 2025
·
7 min read
1 of 29,271
Next
